Loading...
Dacarbazine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Dacarbazine
2025-Q4
Comprehensive analysis of India’s dacarbazine export trade — suppliers, buyers, prices, routes, and every shipment record.
101
Shipments
$66K
Trade Value
40
Suppliers
29
Buyers
35
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/dacarbazine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s dacarbazine trade — 2025-Q4
KEY TAKEAWAY
Dacarbazine 2025-Q4 exports total $65.8K across 35 countries, with NAPROD LIFE SCIENCES PVT LTD commanding 46.2% market share.
TOTAL SHIPMENTS
101
2025-Q4
EXPORT VALUE
$65.8K
FOB USD
TOTAL QUANTITY
29.1K
units shipped
INDIAN SUPPLIERS
40
unique exporters
GLOBAL BUYERS
29
unique importers
DESTINATIONS
35
countries
MEDIAN UNIT PRICE
$1.99
per unit
TOP-5 SHARE
81.8%
of total USD
BRANDED SHARE
70.3%
71 shipments
DOSAGE FORMS
5
product types
6 KEY FINDINGS
1
NAPROD LIFE SCIENCES PVT LTD is India's #1 Dacarbazine exporter with $30.4K (46.2% market share).→ §5, Indian Supplier Rankings
2
Dacarbazine reached 35 countries, with Philippines as the top destination ($30.4K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 2579) — top 10 suppliers control 91.0% of exports.→ §5, Indian Supplier Rankings
4
89.7% of buyers (26 of 29) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Injection dominates (96.6%) across 5 dosage forms.→ §7, Price Benchmarks
6
35 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 NAPROD LIFE SCIENCES PVT LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian dacarbazine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Dacarbazine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial dacarbazine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian dacarbazine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Dacarbazine India trade report
Product scope
Dacarbazine
All variants merged — branded and generic formulations of dacarbazine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
101
Every commercial dacarbazine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $493, Nov $43.1K, Dec $22.2K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$493
Oct USD
2 shipments
2
$43.1K
Nov USD
+8639.4% MoM
3
$22.2K
Dec USD
-48.5% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 8639.4% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $493, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $66K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $43K rise in Nov, $21K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $493 | 2 shipments |
| Nov | $43K | 31 shipments |
| Dec | $22K | 68 shipments |
| Q4 Total | $66K | 101 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Cambodia held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: UNITED BIOTECH PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import dacarbazine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Philippines absorbs 46.2% of India’s 2025-Q4 dacarbazine trade ($30.4K). Beyond the top 10 destinations, 35 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 16 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 35 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much dacarbazine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$44K
66.9% of trade
10 countries · 29 shipments
Europe
$4K
6.0% of trade
3 countries · 3 shipments
Americas
$6K
8.7% of trade
5 countries · 18 shipments
Africa
$12K
18.4% of trade
16 countries · 50 shipments
Oceania
$0
0.0% of trade
1 countries · 1 shipments
Fig 4.1 Philippines is the #1 corridor ($30K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian dacarbazine it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Philippines | $30K | 1 | NAPROD LIFE SCIENCES PVT LTD | $30K | — | — | — | — |
| 2 | Sri Lanka | $8K | 2 | UNITED BIOTECH PVT LTD | $7K | GETWELL PHARMA INDIA PVT LTD | $1K | — | — |
| 3 | Mexico | $5K | 9 | MYGENIC HEALTHCARE PVT LTD | $5K | — | — | — | — |
| 4 | Moldova | $4K | 1 | KWALITY PHARMACEUTICALS LTD | $4K | — | — | — | — |
| 5 | Cambodia | $3K | 3 | UNITED BIOTECH PVT LTD | $3K | VANDAN HEALTHCARE | $374 | — | — |
| 6 | Nigeria | $3K | 6 | ZUVIUS LIFESCIENCES PVT LTD | $3K | — | — | — | — |
| 7 | Zambia | $2K | 1 | RACS PHARMACEUTICALS INDIA PVT LTD | $2K | — | — | — | — |
| 8 | Kenya | $2K | 16 | R.S. SURGIPHARM PVT LTD | $951 | UNITED BIOTECH PVT LTD | $357 | SUBHRA PHARMA PRIAVATE LTD | $314 |
| 9 | Egypt | $1K | 4 | AARIA PHARMACEUTICALS PVT LTD | $1K | AL-ROYAL PHARMACEUTICAL PVT LTD | $51 | BIOZENTA LIFESCIENCE PVT LTD | $26 |
| 10 | Burundi | $1K | 5 | VEA IMPEX (I) PVT LTD | $1K | BRUCK PHARMA PVT LTD | $165 | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 66.9% of USD — but Philippines is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
46.2%
#1 country share
Philippines alone
77.1%
Top 5 share
5 of 35 countries
96.4%
Top 15 share
Long tail of 20 countries = 3.6%
HHI 2452
Destination HHI
Moderately concentrated
35
Countries served
Global pharma reach from India
16
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
40 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
NAPROD LIFE SCIENCES PVT LTD ($30.4K, 46.2% share) and UNITED BIOTECH PVT LTD ($11.6K) together control 63.7% of India’s 2025-Q4 dacarbazine trade. The top 5 suppliers hold 81.8%. 40 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian dacarbazine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 NAPROD LIFE SCIENCES PVT LTD leads by $19K over UNITED BIOTECH PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: SUBHRA PHARMA PRIAVATE is #18 by value but #6 by volume.
Fig 5.2 MYGENIC HEALTHCARE PVT LTD also leads by shipment count (9) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: SUBHRA PHARMA PRIAVATE moves from #6 by volume to #18 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 40 dacarbazine suppliers split into strategic segments
KEY TAKEAWAY
10 suppliers (25%) generate 91.0% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 NAPROD LIFE SCIENCES PVT LTD and UNITED BIOTECH PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 91.0% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | NAPROD LIFE SCIENCES PVT LTD | 1 | 1 | $30K |
| 2 | UNITED BIOTECH PVT LTD | 1 | 4 | $12K |
| 3 | MYGENIC HEALTHCARE PVT LTD | 1 | 1 | $5K |
| 4 | KWALITY PHARMACEUTICALS LTD | 1 | 1 | $4K |
| 5 | ZUVIUS LIFESCIENCES PVT LTD | 1 | 1 | $3K |
| 6 | RACS PHARMACEUTICALS INDIA PVT LTD | 1 | 1 | $2K |
| 7 | AARIA PHARMACEUTICALS PVT LTD | 1 | 1 | $1K |
| 8 | VEA IMPEX (I) PVT LTD | 1 | 1 | $1K |
| 9 | GETWELL PHARMA INDIA PVT LTD | 1 | 2 | $1K |
| 10 | R.S. SURGIPHARM PVT LTD | 1 | 1 | $951 |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the dacarbazine manufacturing hubs
KEY TAKEAWAY
Mumbai and New Delhi together account for $44K of India’s 2025-Q4 dacarbazine trade.
Fig 5.5 Mumbai (9 exporters, $33K) and New Delhi (2 exporters, $11K) are India’s dacarbazine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
81.8%
Top 5 share
5 of 40 suppliers
91.0%
Top 10 share
10 of 40 suppliers
91.0%
Top 25% share
10 suppliers = 91% USD
HHI 2579
Supplier HHI
Concentrated
40
Total suppliers
shipped Dacarbazine in 2025-Q4
20+ cities
Indian hubs
Mumbai and New Delhi lead
§5.2 Coming next: 2 exporter deep-dive profiles
Each of the top 2 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | UNITED BIOTECH PVT LTD | $12K |
| #2 | BARAKAH BIOHEALTH LLP | $495 |
#2
EXPORTER PROFILE #1 OF 2
UNITED BIOTECH PVT LTD
New Delhi · India’s #2 dacarbazine supplier by USD · 2025-Q4
2025-Q4 USD
$12K
17.6% market share
SHIPMENTS
7
avg $2K/ship
COUNTRIES
4
destination markets
BUYERS
5
4 single-sourced
BRANDED
71%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Sri Lanka is the #1 market at $7K (60% of trade), followed by Cambodia at $3K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Sri Lanka | $7K | 1 | 60.5% |
| 2 | Cambodia | $3K | 2 | 26.2% |
| 3 | Nepal | $1K | 3 | 10.2% |
| 4 | Kenya | $357 | 1 | 3.1% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $9K.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| PEOPLES BANK | Sri Lanka | $7K | ⚠ Locked |
| SAK CAM PHARMA CO LTD | Cambodia | $3K | ⚠ Locked |
| NIKHIL PHARMA PVT LTD | Nepal | $777 | ⚠ Locked |
| Undisclosed buyer | Nepal | $408 | N/A |
| SALAMA PHARMACEUTICALS… | Kenya | $357 | ⚠ Locked |
#2
EXPORTER PROFILE #1 OF 2 — TRADE FLOW MAP
UNITED BIOTECH PVT LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P1.3 Sri Lanka absorbs $7K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
#13
EXPORTER PROFILE #2 OF 2
BARAKAH BIOHEALTH LLP
Tiruppur · India’s #13 dacarbazine supplier by USD · 2025-Q4
2025-Q4 USD
$495
0.8% market share
SHIPMENTS
8
avg $62/ship
COUNTRIES
2
destination markets
BUYERS
1
unique importers
BRANDED
100%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Tanzania is the #1 market at $493 (100% of trade), followed by Saudi Arabia at $2. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Tanzania | $493 | 2 | 99.7% |
| 2 | Saudi Arabia | $2 | 6 | 0.3% |
MONTHLY TREND
Oct peaked at $493. Nov was the weakest at $0.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Tanzania | $495 | N/A |
#13
EXPORTER PROFILE #2 OF 2 — TRADE FLOW MAP
BARAKAH BIOHEALTH LLP — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P2.3 Tanzania absorbs $493 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
29 importers across 35 countries — who is buying Indian dacarbazine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 79.2% of total USD. 90% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian dacarbazine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 MULTICARE PHARMACEUTICALS PHILIPPIN is the #1 importer at $30K (46.2%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
90%
Single-source
26 buyers rely on exactly 1 Indian supplier
3%
Dual-source
1 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
7%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source dacarbazine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PEOPLES BANK | UNITED BIOTECH PVT LTD | $7K | $2.333 | Injection |
| THE ESSES PHARMACY (PR… | GETWELL PHARMA INDIA… | $1K | $4.030 | Injection |
Brazil 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SYMONE GABRIELLY DA SI… | NIVIRA EXPORTS | $1.708 | $0.034 | Injection |
| JOAO BATISTA DA SILVA | NIVIRA EXPORTS | $1.708 | $0.034 | Injection |
Philippines 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MULTICARE PHARMACEUTIC… | NAPROD LIFE SCIENCES… | $30K | $4.341 | Injection |
Moldova 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| DITA ESTFARM LLC | KWALITY PHARMACEUTIC… | $4K | $2.196 | Injection |
Cambodia 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SAK CAM PHARMA CO LTD | UNITED BIOTECH PVT LTD | $3K | $3.029 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | MULTICARE PHARMACEUT… | Philippines | $30K | $30K | Mid |
| 2 | PEOPLES BANK | Sri Lanka | $7K | $7K | Budget |
| 3 | DITA ESTFARM LLC | Moldova | $4K | $4K | Budget |
| 4 | SAK CAM PHARMA CO LTD | Cambodia | $3K | $2K | Budget |
| 5 | DOMAKS INVESTMENT LTD | Nigeria | $2K | $474.000 | Budget |
| 6 | JES/108MWAMBULA ROAD | Zambia | $2K | $2K | Budget |
| 7 | THE ESSES PHARMACY (… | Sri Lanka | $1K | $1K | Budget |
| 8 | NIKHIL PHARMA PVT LTD | Nepal | $776.780 | $388.000 | Budget |
| 9 | FOR THE ORDER OF | Bulgaria | $737.487 | $246.000 | Budget |
| 10 | NATIONAL DRUG SERVIC… | Lesotho | $486.716 | $487.000 | Budget |
| 11 | SALAMA PHARMACEUTICA… | Kenya | $356.975 | $357.000 | Budget |
| 12 | MINISTRY OF HEALTH (… | Seychelles | $273.309 | $137.000 | Budget |
| 13 | GULF PHARMACIES W.L.L | Bahrain | $176.948 | $177.000 | Budget |
| 14 | NDZENGUE EBEDE JEAN … | Cameroon | $148.464 | $74.000 | Budget |
| 15 | BREVITEE INTERNATION… | Equatorial Guinea | $133.718 | $134.000 | Budget |
| 16 | PH.EBENA | Cote d'Ivoire | $51.385 | $51.000 | Budget |
| 17 | ROYAL PHARMA COMPANY | Egypt | $50.734 | $51.000 | Budget |
| 18 | WELLPOINT MEDICAL & … | Saint Kitts and Nevis | $39.932 | $20.000 | Budget |
| 19 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | $37.776 | $38.000 | Budget |
| 20 | OUMAR KONE | Mali | $32.524 | $33.000 | Budget |
| 21 | ABU ABDU | Turkey | $12.332 | $2.000 | Budget |
| 22 | SEVEN PHARMA LTDA | Costa Rica | $9.989 | $10.000 | Budget |
| 23 | SUNCREST INTERNATION… | Trinidad and Tobago | $1.997 | $2.000 | Budget |
| 24 | SYMONE GABRIELLY DA … | Brazil | $1.708 | $2.000 | Budget |
| 25 | JOAO BATISTA DA SILVA | Brazil | $1.708 | $2.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 NAPROD LIFE SCIENCES PVT LTD → MULTICARE PHARMACEUTICALS PHILIPPIN is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian dacarbazine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Dacarbazine prices span 6986× ($0.0024 → $16.71). The coefficient of variation is 1.00. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0024 | Lowest observed unit price |
| P5 | $0.013 | 5th percentile |
| P25 | $1.17 | 25th percentile (Q1) |
| Median | $1.99 | 50th percentile (Q2) |
| P75 | $3.25 | 75th percentile (Q3) |
| P95 | $5.52 | 95th percentile |
| Max | $16.71 | Highest observed unit price |
| Mean | $2.37 | Arithmetic average |
| CV | 100% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 SAYAR LIFE-CARE prices at $12.72/unit vs market median $1.99.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. KWALITY PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. NAPROD LIFE SCIENCES Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | SAYAR LIFE-CARE | Seychelles | Tablet | 8 | $133.67 | $16.71 | Specialty / small-batch |
| Dec 2025 | MILTON LIFECARE … | Bahrain | Injection | 20 | $176.95 | $8.85 | Sterile formulation premium |
| Nov 2025 | SAYAR LIFE-CARE | Seychelles | Tablet | 16 | $139.64 | $8.73 | Specialty / small-batch |
| Nov 2025 | VANDAN HEALTHCARE | Cambodia | Injection | 50 | $374.36 | $7.49 | Sterile formulation premium |
| Dec 2025 | UNITED BIOTECH P… | Kenya | Injection | 50 | $356.98 | $7.14 | Sterile formulation premium |
| Dec 2025 | MYGENIC HEALTHCA… | Mexico | Injection | 100 | $465.55 | $4.66 | Sterile formulation premium |
| Dec 2025 | MYGENIC HEALTHCA… | Mexico | Injection | 100 | $465.55 | $4.66 | Sterile formulation premium |
| Dec 2025 | MYGENIC HEALTHCA… | Mexico | Injection | 100 | $465.09 | $4.65 | Sterile formulation premium |
| Dec 2025 | NEOPHAR PHARMACE… | Cameroon | Injection | 100 | $446.40 | $4.46 | Sterile formulation premium |
| Dec 2025 | PIRZE LIFECARE P… | Equatorial Guinea | Other | 30 | $133.72 | $4.46 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | BIOZENTA LIFESCI… | Egypt | Injection | 2K | $5.74 | $0.0024 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 24 | $0.310 | $0.013 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 30 | $0.388 | $0.013 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 88 | $1.14 | $0.013 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 214 | $2.77 | $0.013 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 184 | $2.38 | $0.013 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 374 | $4.83 | $0.013 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 40 | $0.517 | $0.013 | Sterile formulation premium |
| Dec 2025 | RMPL PHARMA LLP | Turkey | Injection | 240 | $3.35 | $0.014 | Sterile formulation premium |
| Dec 2025 | RMPL PHARMA LLP | Turkey | Injection | 260 | $3.63 | $0.014 | Sterile formulation premium |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship dacarbazine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Dacarbazine leaves India through 6+ ports. The top 5 (MUMBAI AIR (SAHAR), DELHI AIR, CHENNAI AIR) handle 100.0% of total USD. AIR moves 98% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUMBAI AIR (SAHAR) handles $43K — top 6 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 MANILA is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 98% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$66K
100.0% of USD · 98.0% of ships
SEA
$4
0.0% of USD · 2.0% of ships
Fig 8.3 The dominant corridor is MUMBAI AIR (SAHAR) → Air → Asia ($30K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Mexico is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 3517).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Mexico (HHI 10,000) is the most concentrated — Kenya (HHI 3,517) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| MULTICARE PHARMACEUT… | Philippines | NAPROD LIFE SCIE… | $30K | 1 | MEDIUM |
| PEOPLES BANK | Sri Lanka | UNITED BIOTECH P… | $7K | 1 | MEDIUM |
| DITA ESTFARM LLC | Moldova | KWALITY PHARMACE… | $4K | 1 | MEDIUM |
| SAK CAM PHARMA CO LTD | Cambodia | UNITED BIOTECH P… | $3K | 2 | MEDIUM |
| DOMAKS INVESTMENT LTD | Nigeria | ZUVIUS LIFESCIEN… | $2K | 4 | MEDIUM |
| JES/108MWAMBULA ROAD | Zambia | RACS PHARMACEUTI… | $2K | 1 | MEDIUM |
| THE ESSES PHARMACY (… | Sri Lanka | GETWELL PHARMA I… | $1K | 1 | MEDIUM |
| NIKHIL PHARMA PVT LTD | Nepal | UNITED BIOTECH P… | $777 | 2 | MEDIUM |
Conclusion: 26 buyers depend on exactly one Indian supplier, representing $51K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Philippines | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mexico | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Moldova | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Cambodia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Zambia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Egypt | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Burundi | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Cameroon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Tanzania | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lesotho | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Philippines | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Mexico lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Philippines (1 suppliers) | This Q | HIGH |
| A6 | Enter Sri Lanka (2 suppliers) | This Q | MED |
| A8 | Build Sri Lanka distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Philippines tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Philippines | Asia | 1 | $30K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Sri Lanka | Asia | 2 | $8K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Mexico | Other | 1 | $5K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Moldova | Other | 1 | $4K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Cambodia | Asia | 2 | $3K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Nigeria | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Zambia | Africa | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Kenya | Africa | 5 | $2K | 0% | LOW | Low competition (5 suppliers), accessible market |
| 9 | Egypt | Africa | 3 | $1K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 10 | Burundi | Africa | 2 | $1K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Nepal | Asia | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Cameroon | Africa | 4 | $985 | 0% | LOW | Low competition (4 suppliers), accessible market |
| 13 | Lebanon | Other | 1 | $530 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Tanzania | Africa | 1 | $493 | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Lesotho | Africa | 1 | $487 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 101 2025-Q4 Dacarbazine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/dacarbazine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 101 2025-Q4 dacarbazine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian dacarbazine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
101
across all regions
TOTAL USD
$66K
2025-Q4 FOB value
UNITS
29.1K
tablets, capsules, etc.
SUPPLIERS
40
Indian exporters
BUYERS
29
global importers
COUNTRIES
35
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $12K (18.4%), spanning 16 countries.
40 Indian suppliers shipped to 29 buyers across 35 countries — average shipment value $651.74.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
16 countries · 50 shipments · $12K · 25 Indian suppliers · 13 buyers
SHIPMENTS
50
USD
$12K
COUNTRIES
16
SUPPLIERS
25
BUYERS
13
HHI
1,125
competitive
Top 16 destination countries in Africa
1
Nigeria (23.7%)
$3K
2
Zambia (15.0%)
$2K
3
Kenya (14.9%)
$2K
4
Egypt (10.7%)
$1K
5
Burundi (9.9%)
$1K
6
Cameroon (8.1%)
$985.08
7
Tanzania (4.1%)
$493.46
8
Lesotho (4.0%)
$486.72
9
Zimbabwe (3.7%)
$443.91
10
Seychelles (2.3%)
$273.31
11
Ethiopia (1.7%)
$201.40
12
Equatorial Guinea (1.1%)
$133.72
13
Cote d'Ivoire (0.4%)
$51.38
14
Mali (0.3%)
$32.52
15
Ghana (0.1%)
$14.29
16
Eswatini (0.0%)
$3.66
Top 25 Indian suppliers into Africa
1
ZUVIUS LIFESCIENCES PVT LTD
$3K
2
RACS PHARMACEUTICALS INDIA PVT LTD
$2K
3
AARIA PHARMACEUTICALS PVT LTD
$1K
4
VEA IMPEX (I) PVT LTD
$1K
5
R.S. SURGIPHARM PVT LTD
$950.59
6
BARAKAH BIOHEALTH LLP
$493.46
7
ACT LIFESCIENCES PVT LTD
$486.72
8
NEOPHAR PHARMACEUTICALS PVT LTD
$446.40
9
3S PHARMACEUTICALS INDIA PVT LTD
$443.91
10
KLV HEALTHCARE PVT LTD
$377.59
11
UNITED BIOTECH PVT LTD
$356.98
12
SUBHRA PHARMA PRIAVATE LTD
$313.97
13
SAYAR LIFE-CARE
$273.31
14
MATOSHREE HEALTH CARE PVT LTD
$201.40
15
BRUCK PHARMA PVT LTD
$164.50
16
RUN MEDWAY
$148.46
17
PIRZE LIFECARE PVT LTD
$133.72
18
RMPL PHARMA LLP
$129.75
19
3S CORP
$56.73
20
SAMEEKSHA PHARMACEUTICALS PVT LTD
$51.38
21
AL-ROYAL PHARMACEUTICAL PVT LTD
$50.73
22
KHATU ENTERPRISES
$32.52
23
BIOZENTA LIFESCIENCE PVT LTD
$29.84
24
RUTVA MEDICARE
$14.29
25
MEDYRA PHARMACEUTICAL
$12.63
Top 11 Africa importers
1
DOMAKS INVESTMENT LTD · Nigeria
$2K
2
JES/108MWAMBULA ROAD · Zambia
$2K
3
FOR THE ORDER OF · Zimbabwe
$500.64
4
NATIONAL DRUG SERVICE ORGANIZATION · Lesotho
$486.72
5
SALAMA PHARMACEUTICALS LTD · Kenya
$356.98
6
MINISTRY OF HEALTH ( CLAUDE JULIEN · Seychelles
$273.31
7
NDZENGUE EBEDE JEAN JOEL · Cameroon
$148.46
8
BREVITEE INTERNATIONAL S.A · Equatorial Guinea
$133.72
9
PH.EBENA · Cote d'Ivoire
$51.38
10
ROYAL PHARMA COMPANY · Egypt
$50.73
11
OUMAR KONE · Mali
$32.52
Top 5 dosage forms
1
Injection
$10K
2
Vial
$2K
3
Tablet
$273.31
4
Other
$133.72
5
Unknown
$14.29
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $493.46 | $246.73 |
| Nov | 16 | $6K | $355.37 |
| Dec | 32 | $6K | $186.36 |
Shipment register · 50 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ZUVIUS LIFESCIENCES PVT LTD · 6 shipments · $3K | |||||||||||
| 1 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 176 | NOS | $1.98 | $347.74 | DELHI AIR | LAGOS | AIR |
| 2 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 324 | NOS | $1.98 | $640.16 | DELHI AIR | LAGOS | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Nigeria | Injection | 176 | NOS | $1.98 | $347.74 | DELHI AIR | LAGOS | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Nigeria | Injection | 324 | NOS | $1.98 | $640.16 | DELHI AIR | LAGOS | AIR |
| 5 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 176 | NOS | $1.81 | $319.33 | DELHI AIR | LAGOS | AIR |
| 6 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 324 | NOS | $1.81 | $587.86 | DELHI AIR | LAGOS | AIR |
| SUPPLIER #2 — RACS PHARMACEUTICALS INDIA PVT LTD · 1 shipments · $2K | |||||||||||
| 7 | Dec 2025 | JES/108MWAMBULA ROAD | Zambia | Injection | 450 | NOS | $4.05 | $2K | DELHI AIR | LUSAKA | AIR |
| SUPPLIER #3 — AARIA PHARMACEUTICALS PVT LTD · 1 shipments · $1K | |||||||||||
| 8 | Nov 2025 | UNLISTED BUYER | Egypt | Injection | 500 | NOS | $2.46 | $1K | MUMBAI AIR (SAHAR) | ALEXANDRIA, EL NHOUZ | AIR |
| SUPPLIER #4 — VEA IMPEX (I) PVT LTD · 4 shipments · $1K | |||||||||||
| 9 | Dec 2025 | UNLISTED BUYER | Burundi | Vial | 100 | NOS | $1.53 | $152.99 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| 10 | Dec 2025 | UNLISTED BUYER | Burundi | Vial | 100 | NOS | $3.67 | $367.18 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| 11 | Dec 2025 | UNLISTED BUYER | Burundi | Vial | 100 | NOS | $1.53 | $152.99 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| 12 | Dec 2025 | UNLISTED BUYER | Burundi | Vial | 100 | NOS | $3.67 | $367.18 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| SUPPLIER #5 — R.S. SURGIPHARM PVT LTD · 7 shipments · $950.59 | |||||||||||
| 13 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 6 | VLS | $2.52 | $15.10 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 14 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 36 | VLS | $2.52 | $90.60 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 15 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 48 | VLS | $2.52 | $120.80 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 16 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 110 | VLS | $2.52 | $276.83 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 17 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 10 | VLS | $2.24 | $22.36 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 18 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 50 | VLS | $2.24 | $111.82 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 19 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 140 | VLS | $2.24 | $313.09 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #6 — BARAKAH BIOHEALTH LLP · 2 shipments · $493.46 | |||||||||||
| 20 | Oct 2025 | UNLISTED BUYER | Tanzania | Injection | 100 | NOS | $3.12 | $312.13 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| 21 | Oct 2025 | UNLISTED BUYER | Tanzania | Injection | 50 | NOS | $3.63 | $181.33 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #7 — ACT LIFESCIENCES PVT LTD · 1 shipments · $486.72 | |||||||||||
| 22 | Nov 2025 | NATIONAL DRUG SERVICE ORGANIZATION | Lesotho | Injection | 200 | NOS | $2.43 | $486.72 | MUMBAI AIR (SAHAR) | MASERU | AIR |
| SUPPLIER #8 — NEOPHAR PHARMACEUTICALS PVT LTD · 1 shipments · $446.40 | |||||||||||
| 23 | Dec 2025 | UNLISTED BUYER | Cameroon | Injection | 100 | VLS | $4.46 | $446.40 | DELHI AIR | DOUALA | AIR |
| SUPPLIER #9 — 3S PHARMACEUTICALS INDIA PVT LTD · 1 shipments · $443.91 | |||||||||||
| 24 | Nov 2025 | FOR THE ORDER OF | Zimbabwe | Injection | 100 | VLS | $4.44 | $443.91 | MUMBAI AIR (SAHAR) | HARARE | AIR |
| SUPPLIER #10 — KLV HEALTHCARE PVT LTD · 1 shipments · $377.59 | |||||||||||
| 25 | Dec 2025 | UNLISTED BUYER | Cameroon | Vial | 100 | NOS | $3.78 | $377.59 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #11 — UNITED BIOTECH PVT LTD · 1 shipments · $356.98 | |||||||||||
| 26 | Dec 2025 | SALAMA PHARMACEUTICALS LTD | Kenya | Injection | 50 | NOS | $7.14 | $356.98 | DELHI AIR | NAIROBI | AIR |
| SUPPLIER #12 — SUBHRA PHARMA PRIAVATE LTD · 6 shipments · $313.97 | |||||||||||
| 27 | Nov 2025 | UNLISTED BUYER | Kenya | Vial | 20 | NOS | $1.82 | $36.40 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 28 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 20 | NOS | $1.82 | $36.45 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 29 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 20 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 30 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 130 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 31 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 20 | NOS | $1.80 | $36.06 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 32 | Dec 2025 | UNLISTED BUYER | Kenya | Vial | 130 | NOS | $1.58 | $205.06 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #13 — SAYAR LIFE-CARE · 2 shipments · $273.31 | |||||||||||
| 33 | Nov 2025 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | Tablet | 16 | NOS | $8.73 | $139.64 | CHENNAI AIR | MAHE ISLAND | AIR |
| 34 | Nov 2025 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | Tablet | 8 | NOS | $16.71 | $133.67 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #14 — MATOSHREE HEALTH CARE PVT LTD · 1 shipments · $201.40 | |||||||||||
| 35 | Dec 2025 | UNKNOWN BUYER | Ethiopia | Injection | 150 | NOS | $1.34 | $201.40 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #15 — BRUCK PHARMA PVT LTD · 1 shipments · $164.50 | |||||||||||
| 36 | Dec 2025 | UNLISTED BUYER | Burundi | Injection | 50 | NOS | $3.29 | $164.50 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| SUPPLIER #16 — RUN MEDWAY · 2 shipments · $148.46 | |||||||||||
| 37 | Nov 2025 | NDZENGUE EBEDE JEAN JOEL | Cameroon | Injection | 50 | NOS | $1.48 | $74.23 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 38 | Nov 2025 | NDZENGUE EBEDE JEAN JOEL | Cameroon | Injection | 50 | NOS | $1.48 | $74.23 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #17 — PIRZE LIFECARE PVT LTD · 1 shipments · $133.72 | |||||||||||
| 39 | Dec 2025 | BREVITEE INTERNATIONAL S.A | Equatorial Guinea | Other | 30 | NOS | $4.46 | $133.72 | AHMEDABAD AIR | MALABO | AIR |
| SUPPLIER #18 — RMPL PHARMA LLP · 1 shipments · $129.75 | |||||||||||
| 40 | Nov 2025 | UNLISTED BUYER | Kenya | Injection | 100 | NOS | $1.30 | $129.75 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #19 — 3S CORP · 1 shipments · $56.73 | |||||||||||
| 41 | Nov 2025 | FOR THE ORDER OF | Kenya | Injection | 50 | VLS | $1.13 | $56.73 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #20 — SAMEEKSHA PHARMACEUTICALS PVT LTD · 1 shipments · $51.38 | |||||||||||
| 42 | Dec 2025 | PH.EBENA | Cote d'Ivoire | Injection | 25 | NOS | $2.06 | $51.38 | MUMBAI AIR (SAHAR) | ABIDJAN | AIR |
| SUPPLIER #21 — AL-ROYAL PHARMACEUTICAL PVT LTD · 1 shipments · $50.73 | |||||||||||
| 43 | Dec 2025 | ROYAL PHARMA COMPANY | Egypt | Injection | 3.0K | NOS | $0.017 | $50.73 | DELHI AIR | ALEXANDRIA, EL NHOUZ | AIR |
| SUPPLIER #22 — KHATU ENTERPRISES · 1 shipments · $32.52 | |||||||||||
| 44 | Dec 2025 | OUMAR KONE | Mali | Injection | 22 | NOS | $1.48 | $32.52 | MUMBAI AIR (SAHAR) | BAMAKO | AIR |
| SUPPLIER #23 — BIOZENTA LIFESCIENCE PVT LTD · 3 shipments · $29.84 | |||||||||||
| 45 | Dec 2025 | UNLISTED BUYER | Eswatini | Injection | 150 | VLS | $0.024 | $3.66 | DELHI AIR | MANZINI | SEA |
| 46 | Dec 2025 | UNLISTED BUYER | Egypt | Injection | 2.4K | NOS | $0.0024 | $5.74 | DELHI AIR | CAIRO | AIR |
| 47 | Dec 2025 | UNLISTED BUYER | Egypt | Injection | 250 | VLS | $0.082 | $20.44 | DELHI AIR | CAIRO | AIR |
| SUPPLIER #24 — RUTVA MEDICARE · 1 shipments · $14.29 | |||||||||||
| 48 | Dec 2025 | UNLISTED BUYER | Ghana | 28 | PCS | $0.510 | $14.29 | AHMEDABAD AIR | ACCRA | AIR | |
| SUPPLIER #25 — MEDYRA PHARMACEUTICAL · 2 shipments · $12.63 | |||||||||||
| 49 | Dec 2025 | UNLISTED BUYER | Cameroon | Injection | 100 | NOS | $0.045 | $4.48 | DELHI AIR | DOUALA | AIR |
| 50 | Dec 2025 | UNLISTED BUYER | Cameroon | Injection | 100 | NOS | $0.082 | $8.15 | DELHI AIR | DOUALA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
10 countries · 29 shipments · $44K · 10 Indian suppliers · 11 buyers
SHIPMENTS
29
USD
$44K
COUNTRIES
10
SUPPLIERS
10
BUYERS
11
HHI
5,415
concentrated
Top 10 destination countries in Asia
1
Philippines (69.0%)
$30K
2
Sri Lanka (18.2%)
$8K
3
Cambodia (7.7%)
$3K
4
Nepal (2.7%)
$1K
5
Lebanon (1.2%)
$530.30
6
Laos (0.7%)
$300.86
7
Bahrain (0.4%)
$176.95
8
United Arab Emirates (0.1%)
$37.78
9
Turkey (0.0%)
$19.31
10
Saudi Arabia (0.0%)
$1.67
Top 10 Indian suppliers into Asia
1
NAPROD LIFE SCIENCES PVT LTD
$30K
2
UNITED BIOTECH PVT LTD
$11K
3
GETWELL PHARMA INDIA PVT LTD
$1K
4
RMPL PHARMA LLP
$537.28
5
VANDAN HEALTHCARE
$374.36
6
ASPIDA LIFE SCIENCES PVT LTD
$300.86
7
MILTON LIFECARE PVT LTD
$176.95
8
HUMANKIND PHARMA
$37.78
9
AMARI TRADE ALLIANCE LLP
$12.33
10
BARAKAH BIOHEALTH LLP
$1.67
Top 9 Asia importers
1
MULTICARE PHARMACEUTICALS PHILIPPIN · Philippines
$30K
2
PEOPLES BANK · Sri Lanka
$7K
3
SAK CAM PHARMA CO LTD · Cambodia
$3K
4
THE ESSES PHARMACY (PRIVATE) · Sri Lanka
$1K
5
NIKHIL PHARMA PVT LTD · Nepal
$776.78
6
GULF PHARMACIES W.L.L · Bahrain
$176.95
7
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$37.78
8
ABU ABDU · Turkey
$12.33
9
KHAMPARN VANGXAIHOUA · Laos
$0.0000
Top 1 dosage forms
1
Injection
$44K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 6 | $33K | $6K |
| Dec | 23 | $11K | $475.47 |
Shipment register · 29 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — NAPROD LIFE SCIENCES PVT LTD · 1 shipments · $30K | |||||||||||
| 1 | Nov 2025 | MULTICARE PHARMACEUTICALS PHILIPPIN | Philippines | Injection | 7.0K | VLS | $4.34 | $30K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| SUPPLIER #2 — UNITED BIOTECH PVT LTD · 6 shipments · $11K | |||||||||||
| 2 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 150 | PCS | $2.72 | $408.33 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Nepal | Injection | 150 | PCS | $2.72 | $408.33 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 4 | Nov 2025 | SAK CAM PHARMA CO LTD | Cambodia | Injection | 500 | VLS | $3.00 | $1K | DELHI AIR | PHNOM PENH - POCHENT | AIR |
| 5 | Dec 2025 | PEOPLES BANK | Sri Lanka | Injection | 3.0K | NOS | $2.33 | $7K | DELHI AIR | COLOMBO | AIR |
| 6 | Dec 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 100 | PCS | $3.68 | $368.45 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 7 | Dec 2025 | SAK CAM PHARMA CO LTD | Cambodia | Injection | 500 | VLS | $3.06 | $2K | DELHI AIR | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #3 — GETWELL PHARMA INDIA PVT LTD · 1 shipments · $1K | |||||||||||
| 8 | Dec 2025 | THE ESSES PHARMACY (PRIVATE) | Sri Lanka | Injection | 250 | NOS | $4.03 | $1K | DELHI AIR | COLOMBO | AIR |
| SUPPLIER #4 — RMPL PHARMA LLP · 3 shipments · $537.28 | |||||||||||
| 9 | Dec 2025 | UNLISTED BUYER | Lebanon | Injection | 400 | NOS | $1.33 | $530.30 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 10 | Dec 2025 | UNLISTED BUYER | Turkey | Injection | 260 | NOS | $0.014 | $3.63 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 11 | Dec 2025 | UNLISTED BUYER | Turkey | Injection | 240 | NOS | $0.014 | $3.35 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #5 — VANDAN HEALTHCARE · 1 shipments · $374.36 | |||||||||||
| 12 | Nov 2025 | UNLISTED BUYER | Cambodia | Injection | 50 | NOS | $7.49 | $374.36 | AHMEDABAD AIR | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #6 — ASPIDA LIFE SCIENCES PVT LTD · 2 shipments · $300.86 | |||||||||||
| 13 | Dec 2025 | KHAMPARN VANGXAIHOUA | Laos | Injection | 200 | NOS | $0.0000 | $0.0000 | DELHI AIR | VIENTIANE | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | Laos | Injection | 200 | NOS | $1.50 | $300.86 | DELHI AIR | VIENTIANE | AIR |
| SUPPLIER #7 — MILTON LIFECARE PVT LTD · 1 shipments · $176.95 | |||||||||||
| 15 | Dec 2025 | GULF PHARMACIES W.L.L | Bahrain | Injection | 20 | NOS | $8.85 | $176.95 | MUMBAI AIR (SAHAR) | BAHRAIN | AIR |
| SUPPLIER #8 — HUMANKIND PHARMA · 1 shipments · $37.78 | |||||||||||
| 16 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Injection | 30 | NOS | $1.26 | $37.78 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| SUPPLIER #9 — AMARI TRADE ALLIANCE LLP · 7 shipments · $12.33 | |||||||||||
| 17 | Dec 2025 | ABU ABDU | Turkey | Injection | 30 | NOS | $0.013 | $0.388 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 18 | Dec 2025 | ABU ABDU | Turkey | Injection | 40 | NOS | $0.013 | $0.517 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 19 | Dec 2025 | ABU ABDU | Turkey | Injection | 214 | NOS | $0.013 | $2.77 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 20 | Dec 2025 | ABU ABDU | Turkey | Injection | 184 | NOS | $0.013 | $2.38 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 21 | Dec 2025 | ABU ABDU | Turkey | Injection | 374 | NOS | $0.013 | $4.83 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 22 | Dec 2025 | ABU ABDU | Turkey | Injection | 88 | NOS | $0.013 | $1.14 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 23 | Dec 2025 | ABU ABDU | Turkey | Injection | 24 | NOS | $0.013 | $0.310 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #10 — BARAKAH BIOHEALTH LLP · 6 shipments · $1.67 | |||||||||||
| 24 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Injection | 10 | NOS | $0.0000 | $0.0000 | CHENNAI AIR | JEDDAH | AIR |
| 25 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Injection | 65 | NOS | $0.0000 | $0.0000 | CHENNAI AIR | JEDDAH | AIR |
| 26 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Injection | 25 | NOS | $0.0000 | $0.0000 | CHENNAI AIR | JEDDAH | AIR |
| 27 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Injection | 10 | NOS | $0.017 | $0.167 | CHENNAI AIR | JEDDAH | AIR |
| 28 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Injection | 65 | NOS | $0.017 | $1.09 | CHENNAI AIR | JEDDAH | AIR |
| 29 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Injection | 25 | NOS | $0.017 | $0.419 | CHENNAI AIR | JEDDAH | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
3 countries · 3 shipments · $4K · 3 Indian suppliers · 3 buyers
SHIPMENTS
3
USD
$4K
COUNTRIES
3
SUPPLIERS
3
BUYERS
3
HHI
8,834
concentrated
Top 3 destination countries in Europe
1
Moldova (93.8%)
$4K
2
Bulgaria (6.0%)
$236.85
3
Italy (0.2%)
$7.09
Top 3 Indian suppliers into Europe
1
KWALITY PHARMACEUTICALS LTD
$4K
2
3S PHARMACEUTICALS INDIA PVT LTD
$236.85
3
ZYPHARS PHARMACEUTICS PVT LTD
$7.09
Top 2 Europe importers
1
DITA ESTFARM LLC · Moldova
$4K
2
FOR THE ORDER OF · Bulgaria
$236.85
Top 1 dosage forms
1
Injection
$4K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 2 | $4K | $2K |
| Dec | 1 | $7.09 | $7.09 |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — KWALITY PHARMACEUTICALS LTD · 1 shipments · $4K | |||||||||||
| 1 | Nov 2025 | DITA ESTFARM LLC | Moldova | Injection | 1.7K | NOS | $2.20 | $4K | DELHI AIR | CHISINAU | AIR |
| SUPPLIER #2 — 3S PHARMACEUTICALS INDIA PVT LTD · 1 shipments · $236.85 | |||||||||||
| 2 | Nov 2025 | FOR THE ORDER OF | Bulgaria | Injection | 100 | VLS | $2.37 | $236.85 | MUMBAI AIR (SAHAR) | SOFIA | AIR |
| SUPPLIER #3 — ZYPHARS PHARMACEUTICS PVT LTD · 1 shipments · $7.09 | |||||||||||
| 3 | Dec 2025 | UNKNOWN BUYER | Italy | Injection | 2 | VLS | $3.55 | $7.09 | MUMBAI AIR (SAHAR) | BOLOGNA | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
5 countries · 18 shipments · $6K · 6 Indian suppliers · 7 buyers
SHIPMENTS
18
USD
$6K
COUNTRIES
5
SUPPLIERS
6
BUYERS
7
HHI
8,668
concentrated
Top 5 destination countries in Americas
1
Mexico (92.9%)
$5K
2
Trinidad and Tobago (5.4%)
$309.47
3
Saint Kitts and Nevis (1.4%)
$79.86
4
Costa Rica (0.2%)
$9.99
5
Brazil (0.1%)
$3.42
Top 6 Indian suppliers into Americas
1
MYGENIC HEALTHCARE PVT LTD
$5K
2
TIGER REMEDIES
$307.47
3
SPR ONCOCARE PVT LTD
$79.86
4
VHB MEDI SCIENCES LTD
$9.99
5
NIVIRA EXPORTS
$3.42
6
GETWELL PHARMA INDIA PVT LTD
$2.00
Top 5 Americas importers
1
WELLPOINT MEDICAL & ONCOLOGY CENTER · Saint Kitts and Nevis
$39.93
2
SEVEN PHARMA LTDA · Costa Rica
$9.99
3
SUNCREST INTERNATIONAL LTD · Trinidad and Tobago
$2.00
4
SYMONE GABRIELLY DA SILVA COSTA · Brazil
$1.71
5
JOAO BATISTA DA SILVA · Brazil
$1.71
Top 3 dosage forms
1
Injection
$6K
2
Unknown
$41.93
3
mg
$39.93
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 7 | $399.32 | $57.05 |
| Dec | 11 | $5K | $481.85 |
Shipment register · 18 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MYGENIC HEALTHCARE PVT LTD · 9 shipments · $5K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 300 | NOS | $1.84 | $551.32 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 2 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 200 | NOS | $3.75 | $749.37 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 3 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 100 | NOS | $4.66 | $465.55 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 4 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 300 | NOS | $1.84 | $551.32 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 5 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 200 | NOS | $3.75 | $749.37 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 6 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 100 | NOS | $4.66 | $465.55 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 7 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 300 | NOS | $1.84 | $550.76 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 8 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 200 | NOS | $3.74 | $748.63 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 9 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 100 | NOS | $4.65 | $465.09 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #2 — TIGER REMEDIES · 1 shipments · $307.47 | |||||||||||
| 10 | Nov 2025 | UNLISTED BUYER | Trinidad and Tobago | Injection | 100 | NOS | $3.07 | $307.47 | MUMBAI AIR (SAHAR) | PORT OF SPAIN, PIARC | AIR |
| SUPPLIER #3 — SPR ONCOCARE PVT LTD · 4 shipments · $79.86 | |||||||||||
| 11 | Nov 2025 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 10 | NOS | $2.00 | $19.97 | BANGALORE AIR | NEVIS | AIR | |
| 12 | Nov 2025 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 10 | NOS | $2.00 | $19.97 | BANGALORE AIR | NEVIS | AIR | |
| 13 | Nov 2025 | UNKNOWN BUYER | Saint Kitts and Nevis | mg | 10 | NOS | $2.00 | $19.97 | BANGALORE AIR | NEVIS | AIR |
| 14 | Nov 2025 | UNKNOWN BUYER | Saint Kitts and Nevis | mg | 10 | NOS | $2.00 | $19.97 | BANGALORE AIR | NEVIS | AIR |
| SUPPLIER #4 — VHB MEDI SCIENCES LTD · 1 shipments · $9.99 | |||||||||||
| 15 | Nov 2025 | SEVEN PHARMA LTDA | Costa Rica | Injection | 32 | VLS | $0.312 | $9.99 | MUMBAI AIR (SAHAR) | SAN JOSE | AIR |
| SUPPLIER #5 — NIVIRA EXPORTS · 2 shipments · $3.42 | |||||||||||
| 16 | Dec 2025 | SYMONE GABRIELLY DA SILVA COSTA | Brazil | Injection | 50 | SET | $0.034 | $1.71 | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
| 17 | Dec 2025 | JOAO BATISTA DA SILVA | Brazil | Injection | 50 | SET | $0.034 | $1.71 | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
| SUPPLIER #6 — GETWELL PHARMA INDIA PVT LTD · 1 shipments · $2.00 | |||||||||||
| 18 | Nov 2025 | SUNCREST INTERNATIONAL LTD | Trinidad and Tobago | 2 | NOS | $0.998 | $2.00 | DELHI AIR | PORT OF SPAIN, PIARC | AIR | |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $0.0000 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$0.0000
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
NaN
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea · Papua New Guinea
$0.0000
Top 1 Indian suppliers into Oceania
1
ARIHANT EXPORTERS
$0.0000
Top 1 Oceania importers
1
SESAGO HEALTHCARE LTD · Papua New Guinea
$0.0000
Top 1 dosage forms
1
Injection
$0.0000
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $0.0000 | $0.0000 |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ARIHANT EXPORTERS · 1 shipments · $0.0000 | |||||||||||
| 1 | Dec 2025 | SESAGO HEALTHCARE LTD | Papua New Guinea | Injection | 150 | PCS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 40 Indian dacarbazine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped dacarbazine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | NAPROD LIFE SCIENCES PVT LTD | MUMBAI | 1 | $30K | Injection | Asia |
| 2 | UNITED BIOTECH PVT LTD | NEW DELHI | 7 | $12K | Injection | Asia, Africa |
| 3 | MYGENIC HEALTHCARE PVT LTD | NAVI MUMBAI | 9 | $5K | Injection | Americas |
| 4 | KWALITY PHARMACEUTICALS LTD | AMRITSAR | 1 | $4K | Injection | Europe |
| 5 | ZUVIUS LIFESCIENCES PVT LTD | GHATKOPAR (E) | 6 | $3K | Injection | Africa |
| 6 | RACS PHARMACEUTICALS INDIA PVT LTD | Noida | 1 | $2K | Injection | Africa |
| 7 | AARIA PHARMACEUTICALS PVT LTD | VADODARA | 1 | $1K | Injection | Africa |
| 8 | VEA IMPEX (I) PVT LTD | MUMBAI | 4 | $1K | Vial | Africa |
| 9 | GETWELL PHARMA INDIA PVT LTD | GURGAON | 2 | $1K | Injection | Americas, Asia |
| 10 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 7 | $950.59 | Injection | Africa |
| 11 | 3S PHARMACEUTICALS INDIA PVT LTD | MUMBAI | 2 | $680.75 | Injection | Europe, Africa |
| 12 | RMPL PHARMA LLP | MUMBAI | 4 | $667.03 | Injection | Africa, Asia |
| 13 | BARAKAH BIOHEALTH LLP | TIRUPPUR | 8 | $495.14 | Injection | Africa, Asia |
| 14 | ACT LIFESCIENCES PVT LTD | VASHI | 1 | $486.72 | Injection | Africa |
| 15 | NEOPHAR PHARMACEUTICALS PVT LTD | DELHI | 1 | $446.40 | Injection | Africa |
| 16 | KLV HEALTHCARE PVT LTD | DAHISAR | 1 | $377.59 | Vial | Africa |
| 17 | VANDAN HEALTHCARE | AHMEDABAD | 1 | $374.36 | Injection | Asia |
| 18 | SUBHRA PHARMA PRIAVATE LTD | Navghar Mulund East Mumbai | 6 | $313.97 | Vial | Africa |
| 19 | TIGER REMEDIES | SURAT | 1 | $307.47 | Injection | Americas |
| 20 | ASPIDA LIFE SCIENCES PVT LTD | GHAZIABAD | 2 | $300.86 | Injection | Asia |
| 21 | SAYAR LIFE-CARE | Chennai | 2 | $273.31 | Tablet | Africa |
| 22 | MATOSHREE HEALTH CARE PVT LTD | THAKURDWAR MUMBAI | 1 | $201.40 | Injection | Africa |
| 23 | MILTON LIFECARE PVT LTD | MUMBAI | 1 | $176.95 | Injection | Asia |
| 24 | BRUCK PHARMA PVT LTD | NANI | 1 | $164.50 | Injection | Africa |
| 25 | RUN MEDWAY | SURAT | 2 | $148.46 | Injection | Africa |
| 26 | PIRZE LIFECARE PVT LTD | AHMEDABAD | 1 | $133.72 | Other | Africa |
| 27 | SPR ONCOCARE PVT LTD | BANGALORE | 4 | $79.86 | mg | Americas |
| 28 | 3S CORP | MUMBAI | 1 | $56.73 | Injection | Africa |
| 29 | SAMEEKSHA PHARMACEUTICALS PVT LTD | PUNE | 1 | $51.38 | Injection | Africa |
| 30 | AL-ROYAL PHARMACEUTICAL PVT LTD | NEW DELHI | 1 | $50.73 | Injection | Africa |
| 31 | HUMANKIND PHARMA | Mumbai | 1 | $37.78 | Injection | Asia |
| 32 | KHATU ENTERPRISES | NAGPUR | 1 | $32.52 | Injection | Africa |
| 33 | BIOZENTA LIFESCIENCE PVT LTD | Una | 3 | $29.84 | Injection | Africa |
| 34 | RUTVA MEDICARE | SURAT | 1 | $14.29 | Africa | |
| 35 | MEDYRA PHARMACEUTICAL | DELHI | 2 | $12.63 | Injection | Africa |
| 36 | AMARI TRADE ALLIANCE LLP | MUMBAI | 7 | $12.33 | Injection | Asia |
| 37 | VHB MEDI SCIENCES LTD | UDHAMSINGH NAGAR | 1 | $9.99 | Injection | Americas |
| 38 | ZYPHARS PHARMACEUTICS PVT LTD | PUNE | 1 | $7.09 | Injection | Europe |
| 39 | NIVIRA EXPORTS | MUMBAI | 2 | $3.42 | Injection | Americas |
| 40 | ARIHANT EXPORTERS | SURENDRANAGAR | 1 | $0.0000 | Injection | Oceania |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 27 global dacarbazine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian dacarbazine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | MULTICARE PHARMACEUTICALS PHILIPPIN | Philippines | 1 | $30K | NAPROD LIFE SCIENCES… | Injection |
| 2 | PEOPLES BANK | Sri Lanka | 1 | $7K | UNITED BIOTECH PVT LTD | Injection |
| 3 | DITA ESTFARM LLC | Moldova | 1 | $4K | KWALITY PHARMACEUTIC… | Injection |
| 4 | SAK CAM PHARMA CO LTD | Cambodia | 2 | $3K | UNITED BIOTECH PVT LTD | Injection |
| 5 | DOMAKS INVESTMENT LTD | Nigeria | 4 | $2K | ZUVIUS LIFESCIENCES … | Injection |
| 6 | JES/108MWAMBULA ROAD | Zambia | 1 | $2K | RACS PHARMACEUTICALS… | Injection |
| 7 | THE ESSES PHARMACY (PRIVATE) | Sri Lanka | 1 | $1K | GETWELL PHARMA INDIA… | Injection |
| 8 | NIKHIL PHARMA PVT LTD | Nepal | 2 | $776.78 | UNITED BIOTECH PVT LTD | Injection |
| 9 | FOR THE ORDER OF | Bulgaria | 3 | $737.49 | 3S PHARMACEUTICALS I… | Injection |
| 10 | NATIONAL DRUG SERVICE ORGANIZATION | Lesotho | 1 | $486.72 | ACT LIFESCIENCES PVT… | Injection |
| 11 | SALAMA PHARMACEUTICALS LTD | Kenya | 1 | $356.98 | UNITED BIOTECH PVT LTD | Injection |
| 12 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | 2 | $273.31 | SAYAR LIFE-CARE | Tablet |
| 13 | GULF PHARMACIES W.L.L | Bahrain | 1 | $176.95 | MILTON LIFECARE PVT … | Injection |
| 14 | NDZENGUE EBEDE JEAN JOEL | Cameroon | 2 | $148.46 | RUN MEDWAY | Injection |
| 15 | BREVITEE INTERNATIONAL S.A | Equatorial Guinea | 1 | $133.72 | PIRZE LIFECARE PVT LTD | Other |
| 16 | PH.EBENA | Cote d'Ivoire | 1 | $51.38 | SAMEEKSHA PHARMACEUT… | Injection |
| 17 | ROYAL PHARMA COMPANY | Egypt | 1 | $50.73 | AL-ROYAL PHARMACEUTI… | Injection |
| 18 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 2 | $39.93 | SPR ONCOCARE PVT LTD | |
| 19 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 1 | $37.78 | HUMANKIND PHARMA | Injection |
| 20 | OUMAR KONE | Mali | 1 | $32.52 | KHATU ENTERPRISES | Injection |
| 21 | ABU ABDU | Turkey | 7 | $12.33 | AMARI TRADE ALLIANCE… | Injection |
| 22 | SEVEN PHARMA LTDA | Costa Rica | 1 | $9.99 | VHB MEDI SCIENCES LTD | Injection |
| 23 | SUNCREST INTERNATIONAL LTD | Trinidad and Tobago | 1 | $2.00 | GETWELL PHARMA INDIA… | |
| 24 | SYMONE GABRIELLY DA SILVA COSTA | Brazil | 1 | $1.71 | NIVIRA EXPORTS | Injection |
| 25 | JOAO BATISTA DA SILVA | Brazil | 1 | $1.71 | NIVIRA EXPORTS | Injection |
| 26 | KHAMPARN VANGXAIHOUA | Laos | 1 | $0.0000 | ASPIDA LIFE SCIENCES… | Injection |
| 27 | SESAGO HEALTHCARE LTD | Papua New Guinea | 1 | $0.0000 | ARIHANT EXPORTERS | Injection |
This report covers 101 2025-Q4 Dacarbazine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/dacarbazine
Talk to our trade analyst
Need a custom dacarbazine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/dacarbazine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Dacarbazine product page
Live data, supplier directory, price trends, and trade route analysis